The Week in Review: November 10 – November 17, 2017

Friday, November 17, 2017 News Recap: AASLD 2017 HCV Clinical Guidelines and Patient Management highlights from The Liver Meeting 2017. Thanks to the Canadian Society for International Health we are able to share this excellent presentation, by Dr. Curtis Cooper, on highlights from AASLD 2017. Liver Cancer Global Perspectives on Hepatocellular Carcinoma.  Be sure to check out this excellent article! A panel of international oncology experts rece...

U.S.: Dynavax Announces FDA Approval of HEPLISAV-B™ for Prevention of Hepatitis B in Adults

First and Only Two-Dose Vaccine in United States for Prevention of Hepatitis B in Adults. First New Hepatitis B Vaccine in United States in More than 25 Years.  BERKELEY, CA--(Marketwired - November 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hep